These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8293436)

  • 1. [Consupren in prophylactic therapy after kidney transplantation].
    Matl I; Jirka J; Petrásek R
    Cas Lek Cesk; 1993 Nov; 132(22):687-90. PubMed ID: 8293436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Graft rejection after changing from cyclosporin A therapy to conventional treatment in kidney transplant patients].
    Matl I; Gintelová J; Jirka J; Rossmann P
    Cas Lek Cesk; 1993 May; 132(10):301-4. PubMed ID: 8513465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preventive administration of antithymocyte globulin in combined immunosuppressive therapy with cyclosporin A, azathioprine and prednisone in kidney transplantation].
    Matl I; Kaslíková J; Jirka J
    Cas Lek Cesk; 1991 Mar; 130(12):364-6. PubMed ID: 2032265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclosporin A in preventive therapy after kidney transplantation: a double combination versus a triple combination. I. Therapeutic effectiveness].
    Matl I; Jirka J; Kocandrle V; Petrásek R
    Cas Lek Cesk; 1990 May; 129(18):550-3. PubMed ID: 2350773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Withdrawal of prednisone from a triple combination of immunosuppressive agents after kidney transplantation].
    Matl I; Lácha J; Lodererová A; Símová M; Teplan V; Lánská V; Vítko S
    Cas Lek Cesk; 2000 Mar; 139(4):115-9. PubMed ID: 10838741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conversion from Consupren sol. to Consupren S capsules in kidney transplant patients].
    Matl I; Vítko S; Bubenícek P; Horcicková M; Lácha J; Lánská V; Marecková O; Nosková L; Petrásek R; Reneltová I; Táborský P
    Vnitr Lek; 1999 Mar; 45(3):167-9. PubMed ID: 15641241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients.
    Câmara NO; Dias MF; Pacheco-Silva A
    Clin Transplant; 2004 Aug; 18(4):450-5. PubMed ID: 15233825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Change from treatment with cyclosporin A to conventional treatment in kidney transplantation].
    Matl I; Jirka J; Kocandrle V
    Cas Lek Cesk; 1990 Nov; 129(46):1453-6. PubMed ID: 2249245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A single-center controlled clinical study with Sandimmune Neoral after kidney transplantation].
    Matl I; Vítko S; Lácha J; Horcicková M; Nosková L; Símová M; Táborský P; Viklický O; Hulínský V; Lánská V
    Vnitr Lek; 1997 Nov; 43(11):703-6. PubMed ID: 9650498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Initial clinical experience with Consupren, a new preparation manufactured in Czechoslovakia (Galena), in patients after liver transplantation].
    Matl I; Petrásek R; Klíma J; Jirka J; Kocandrle V
    Cas Lek Cesk; 1992 Jan; 131(1):25-7. PubMed ID: 1559251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kidney-pancreas transplantation. Clinical results in 23 consecutive patients].
    Maestri M; Krieger N; Kuo P; Dafoe DC; Alfrey EJ
    Minerva Chir; 1998 Mar; 53(3):121-8. PubMed ID: 9617106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
    Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
    Herman M; Weinstein T; Korzets A; Chagnac A; Ori Y; Zevin D; Malachi T; Gafter U
    J Lab Clin Med; 2001 Jan; 137(1):14-20. PubMed ID: 11150019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate for rejection prophylaxis after heart transplantation.
    Taylor DO; Olsen SL; Ensley RD; Renlund DG
    J Heart Lung Transplant; 1995; 14(5):950-4. PubMed ID: 8800732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine mono-drug therapy.
    Salaman J
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):117-20. PubMed ID: 3291223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the effects of 2 preparations of cyclosporin A-- Consupren and Sandimmune--from the aspect of functional and morphologic changes in rats with renal ischemia].
    Bohdanecká M; Chadimová M; Schück O; Petrásek B; Reitschlägerová V
    Cas Lek Cesk; 1994 Jan; 133(3):71-5. PubMed ID: 8137375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.